摘要
目的对2012年军队评价性抽验肌苷片质量现状进行评价。方法对在全军范围内抽取的245批次肌苷片按《部颁标准》二部第六册(生化药品第一分册)1998年版、《中国药典》2005年版二部和2010年版二部进行全项检验,并对检验结果进行了统计分析。结果 245批次肌苷片样品质量均符合标准规定。结论目前国内肌苷片的生产工艺较为稳定,肌苷片质量总体较好,但个别生产厂家的产品需加强监督,其质量标准还需进一步充实和完善。
Objective To explore the molar condition of the legionary evaluation testing of inosine tablets in 2012. Methods The quality of 245 batches of inosine tablets selectived in legionary were detected according to the Chinese Pharmacopoeia（ 2005 edition, second volume ;2010 edition, second volume）and the results were statistically analyzed. Results The quality of 245 batches of inosine tablets met a criterion. Conclusion At present the process and quality of production of inosine tablets is relatively stable in China and the total quality is fine, but some manufacturers need to strengthen the supervision and management, and the quality standards of inosine tablets need to be further improved.
出处
《实用药物与临床》
CAS
2013年第12期1190-1193,共4页
Practical Pharmacy and Clinical Remedies
关键词
肌苷片
评价性抽验
质量分析
Inosine tablets
Selective examination
Quality analysis
